Long Phi Le, MD, PhD
Assistant in Pathology, Massachusetts General Hospital
Assistant Professor of Pathology, Harvard Medical School
Dr. Le is a molecular pathologist and bioinformatics scientist with expertise in cancer tumor genotyping for targeted therapies in personalized medicine. He is a member of the Center for Integrated Diagnostics.
- Department of Pathology
- Clinical Interests
- Molecular pathology
- Boston: Massachusetts General Hospital
- Medical Education
- MD, PhD, University of Alabama School of Medicine
- Residency, Massachusetts General Hospital
- Fellowship, Brigham and Women's Hospital
- Board Certifications
- Clinical Pathology/Laboratory Medicine, American Board of Pathology
- Molecular Genetic Pathology, American Board of Medical Genetics
- Foreign Languages
- Accepting New Patients
- Accepting New Patients
- Insurances Accepted
- Aetna Health Inc.
Blue Cross Blue Shield - Blue Care 65
Blue Cross Blue Shield - Indemnity
Blue Cross Blue Shield - Managed Care
Blue Cross Blue Shield - Partners Plus
Cigna (PAL #'s)
Fallon Community HealthCare
Great-West Healthcare (formally One Health Plan)
Harvard Pilgrim Health Plan - ACD
Harvard Pilgrim Health Plan - PBO
Health Care Value Management (HCVM)
Humana/Choice Care PPO
Medicare - ACD
Neighborhood Health Plan - ACD
Neighborhood Health Plan - PBO
OSW - Maine
OSW - New Hampshire
OSW - Rhode Island
Private Health Care Systems (PHCS)
Railroad Medicare - ACD
Senior Whole Health
Tufts Health Plan
United Healthcare (non-HMO) - ACD
United Healthcare (non-HMO) - PBO
Dr. Long Phi Le is a graduate of Massachusetts Institute of Technology (1999) and received his MD and PhD from the University of Alabama at Birmingham School of Medicine in 2006. He completed his residency training in Clinical Pathology at the Massachusetts General Hospital and his Molecular Genetic Pathology Fellowship at Brigham and Women's Hospital (2010). He joined the Mass General Pathology Department in 2010. His clinical and research interests in the Center for Integrated Diagnostics (formerly the Diagnostic Molecular Pathology Laboratory) include the application of copy number analysis, next generation sequencing, and bioinformatics in molecular diagnostics.
For information about research concepts, publications, and co-authors visit Dr. Le?s research profile at the Harvard Clinical and Translational Science Center.
View my most recent publications at PubMed
- Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer. O'Brien TD, Jia P, Xia J, Saxena U, Jin H, Vuong H, Kim P, Wang Q, Aryee MJ, Mino-Kenudson M, Engelman JA, Le LP, Iafrate AJ, Heist RS, Pao W, Zhao Z. Methods. 2015 Apr 23
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N, Khayter C, Iafrate AJ, Le LP, Aryee MJ, Joung JK. Nat Biotechnol. 2015 Feb
- Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens. Carey CD, Gusenleitner D, Chapuy B, Kovach AE, Kluk MJ, Sun HH, Crossland RE, Bacon CM, Rand V, Dal Cin P, Le LP, Neuberg D, Sohani AR, Shipp MA, Monti S, Rodig SJ. J Mol Diagn. 2015 Jan
- Anchored multiplex PCR for targeted next-generation sequencing. Zheng Z, Liebers M, Zhelyazkova B, Cao Y, Panditi D, Lynch KD, Chen J, Robinson HE, Shim HS, Chmielecki J, Pao W, Engelman JA, Iafrate AJ, Le LP. Nat Med. 2014 Dec
55 Fruit Street
Boston, MA 02114-2696
Call the Massachusetts General Hospital physician referral service at 800-711-4644.
Mass General accepts most health insurance plans. Find out what you need to know before coming to Mass General.
Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.